Episode two: GLP-1s, Weight Bias and the Future of Obesity Care
| Dr. Jordanna Kapeluto is a Clinical Assistant Professor in the UBC Division of Endocrinology. She specializes in the management of obesity and metabolic diseases, with a research focus on the clinical outcomes of metabolic disease following bariatric surgery. She completed her medical training at UBC and pursued advanced training in obesity medicine and bariatric surgery at Laval University before joining the faculty. A leading expert in endocrine care for obesity and related metabolic disorders, Dr. Kapeluto’s work explores how new malabsorptive metabolic surgeries and emerging therapies can induce remission of diabetes, obstructive sleep apnea, and non-alcoholic fatty liver disease, to identify which patient populations benefit most from these interventions. Dr. Kapeluto is actively involved in clinical care and research at the Richmond Metabolic and Bariatric Surgery Program and the Vancouver General Hospital Bariatric Clinic, as well as the Health Heart Lipid Prevention Clinic. She is recognized for teaching and clinical excellence, having received the UBC Department of Medicine Teaching Excellence Award (2021, 2020), the CSEM Dr. John Dupré Award (2017), and multiple Endocrine Society awards. |
In this episode, endocrinologist Dr. Jordanna Kapeluto unpacks the evolving science of obesity and the role of GLP-1 medications like semaglutide. We explore obesity as a complex, chronic disease, the impact of weight bias in health care, and the promise and pitfalls of new treatments. From mechanisms of action to real-world outcomes, this conversation challenges assumptions and highlights the importance of compassionate, evidence-based care.
Meet your host
